CAS 514-36-3|Fludrocortisone acetate
| Common Name | Fludrocortisone acetate | ||
|---|---|---|---|
| CAS Number | 514-36-3 | Molecular Weight | 422.487 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 575.1±50.0 °C at 760 mmHg |
| Molecular Formula | C23H31FO6 | Melting Point | 233-234°C |
| MSDS | ChineseUSA | Flash Point | 301.6±30.1 °C |
| Symbol | GHS07, GHS08 | Signal Word | Warning |
Names
| Name | fludrocortisone acetate |
|---|---|
| Synonym | More Synonyms |
Fludrocortisone acetate BiologicalActivity
| Description | Fludrocortisone Acetate is a synthetic mineralocorticoid, used to control the amount of sodium and fluids in your body. It is used to treat Addison's disease by decreasing the amount of sodium that is lost (excreted) in your urine,also used to increase blood pressure. |
|---|---|
| Related Catalog | Signaling Pathways >>Autophagy >>AutophagySignaling Pathways >>Metabolic Enzyme/Protease >>Mineralocorticoid ReceptorResearch Areas >>Inflammation/Immunology |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 575.1±50.0 °C at 760 mmHg |
| Melting Point | 233-234°C |
| Molecular Formula | C23H31FO6 |
| Molecular Weight | 422.487 |
| Flash Point | 301.6±30.1 °C |
| Exact Mass | 422.210480 |
| PSA | 100.90000 |
| LogP | 2.32 |
| Vapour Pressure | 0.0±3.6 mmHg at 25°C |
| Index of Refraction | 1.564 |
| InChIKey | SYWHXTATXSMDSB-GSLJADNHSA-N |
| SMILES | CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3(F)C(O)CC21C |
| Storage condition | -20°C Freezer |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >1 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 18,666,1987
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 240 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 18,666,1987
Safety Information
| Symbol | GHS07, GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H361 |
| Precautionary Statements | P280-P301 + P312 + P330 |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R63 |
| Safety Phrases | S22-S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | TU5050000 |
| HS Code | 2937229000 |
Customs
| HS Code | 2937229000 |
|---|
Articles28
More Articles| Importance of a suitable working protocol for tape stripping experiments on porcine ear skin: Influence of lipophilic formulations and strip adhesion impairment. Int. J. Pharm. 491 , 162-9, (2015) The tape stripping method is a very important tool for dermopharmacokinetic experiments in vitro and the accurate measurement of the removed corneocytes is key for a reliable calculation of a drug's s... | |
| Dilution of semi-solid creams: influence of various production parameters on rheological properties and skin penetration. Int. J. Pharm. 478(2) , 429-38, (2015) In order to customise treatment for patients, topical formulations are often diluted with drug-free cream bases to adjust the drug dose and thereby the formulations' activity to the patients' needs. H... | |
| Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity. Cancer Chemother. Pharmacol. 74(2) , 249-55, (2014) A synthetic glucocorticoid, dexamethasone, was recently shown to inhibit bladder cancer cell invasion and metastasis through the glucocorticoid receptor (GR) pathway but increased cell proliferation v... |
Synonyms
| 9-Fluoro-11-β,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate |
| Corticosterone, 9-fluoro-17-hydroxy-, 21-acetate |
| fludrocortisone 21-acetate |
| 9-Fluoro-11β,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate |
| Alflorone |
| Pregn-4-ene-3,20-dione, 9-fluoro-11-β,17,21-trihydroxy-, 21-acetate |
| Cortisol, 9-fluoro-, 21-acetate |
| F-Cortef |
| Fludrocortisone acetate |
| 2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl acetate |
| EINECS 208-180-4 |
| Pregn-4-ene-3,20-dione, 9-fluoro-11β,17,21-trihydroxy-, 21-acetate (8CI) |
| MFCD00864160 |
| acétate de 2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-diméthyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-1H-cyclopenta[a]phénanthrén-17-yl]-2-oxoéthyle |
| FLORINEF |
| pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11b)- |
| 2-[(8S,9R,10S,11S,13S,14S,17R)-9-Fluor-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethylacetat |
| (11β)-9-Fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate |
| (11b)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate |
| Pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11β)- |
| Scherofluron |
| Fludrocortisone (acetate) |
